These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29522901)

  • 1. The influence of CYP1A2 genotype in the blood pressure response to caffeine ingestion is affected by physical activity status and caffeine consumption level.
    Soares RN; Schneider A; Valle SC; Schenkel PC
    Vascul Pharmacol; 2018 Jul; 106():67-73. PubMed ID: 29522901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women.
    Arciero PJ; Ormsbee MJ
    Appl Physiol Nutr Metab; 2009 Aug; 34(4):754-62. PubMed ID: 19767812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study.
    Rahimi R
    Ir J Med Sci; 2019 Feb; 188(1):337-345. PubMed ID: 29532291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.
    Barreto G; Grecco B; Merola P; Reis CEG; Gualano B; Saunders B
    Eur J Appl Physiol; 2021 Mar; 121(3):749-769. PubMed ID: 33403509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of
    Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 Genotype Variations Do Not Modify the Benefits and Drawbacks of Caffeine during Exercise: A Pilot Study.
    Salinero JJ; Lara B; Ruiz-Vicente D; Areces F; Puente-Torres C; Gallo-Salazar C; Pascual T; Del Coso J
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine intake reduces incident atrial fibrillation at a population level.
    Casiglia E; Tikhonoff V; Albertini F; Gasparotti F; Mazza A; Montagnana M; Danese E; Benati M; Spinella P; Palatini P
    Eur J Prev Cardiol; 2018 Jul; 25(10):1055-1062. PubMed ID: 29692210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance.
    Grgic J; Pickering C; Bishop DJ; Schoenfeld BJ; Mikulic P; Pedisic Z
    J Int Soc Sports Nutr; 2020 Apr; 17(1):21. PubMed ID: 32295624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension.
    Guessous I; Dobrinas M; Kutalik Z; Pruijm M; Ehret G; Maillard M; Bergmann S; Beckmann JS; Cusi D; Rizzi F; Cappuccio F; Cornuz J; Paccaud F; Mooser V; Gaspoz JM; Waeber G; Burnier M; Vollenweider P; Eap CB; Bochud M
    Hum Mol Genet; 2012 Jul; 21(14):3283-92. PubMed ID: 22492992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CYP1A2 -163C>A polymorphism does not alter the effects of caffeine on basketball performance.
    Puente C; Abián-Vicén J; Del Coso J; Lara B; Salinero JJ
    PLoS One; 2018; 13(4):e0195943. PubMed ID: 29668752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine and 3-km cycling performance: Effects of mouth rinsing, genotype, and time of day.
    Pataky MW; Womack CJ; Saunders MJ; Goffe JL; D'Lugos AC; El-Sohemy A; Luden ND
    Scand J Med Sci Sports; 2016 Jun; 26(6):613-9. PubMed ID: 26062916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.
    Josse AR; Da Costa LA; Campos H; El-Sohemy A
    Am J Clin Nutr; 2012 Sep; 96(3):665-71. PubMed ID: 22854411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
    Guest N; Corey P; Vescovi J; El-Sohemy A
    Med Sci Sports Exerc; 2018 Aug; 50(8):1570-1578. PubMed ID: 29509641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of genetic polymorphisms and habitual caffeine intake on the changes in blood pressure, pulse rate, and calculation speed after caffeine intake: A prospective, double blind, randomized trial in healthy volunteers.
    Yoshihara T; Zaitsu M; Shiraishi F; Arima H; Takahashi-Yanaga F; Arioka M; Kajioka S; Sasaguri T
    J Pharmacol Sci; 2019 Mar; 139(3):209-214. PubMed ID: 30773300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial glycaemic and lipaemic responses to chronic coffee consumption may be modulated by CYP1A2 polymorphisms.
    Robertson TM; Clifford MN; Penson S; Williams P; Robertson MD
    Br J Nutr; 2018 Apr; 119(7):792-800. PubMed ID: 29569539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls.
    Petersen MS; Halling J; Damkier P; Nielsen F; Grandjean P; Weihe P; Brøsen K
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1041-8. PubMed ID: 17089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.
    Zhou A; Hyppönen E
    Am J Clin Nutr; 2019 Mar; 109(3):509-516. PubMed ID: 30838377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.
    Koonrungsesomboon N; Khatsri R; Wongchompoo P; Teekachunhatean S
    Pharmacogenomics J; 2018 Dec; 18(6):760-768. PubMed ID: 29282363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a CYP1A2 polymorphism on post-exercise heart rate variability in response to caffeine intake: a double-blind, placebo-controlled trial.
    Thomas RM; Algrain HA; Ryan EJ; Popojas A; Carrigan P; Abdulrahman A; Carrillo AE
    Ir J Med Sci; 2017 May; 186(2):285-291. PubMed ID: 27363424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.